131 related articles for article (PubMed ID: 2579225)
21. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
Momburg F; Koretz K; Von Herbay A; Möller P
Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
[TBL] [Abstract][Full Text] [Related]
22. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
23. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
Norton AJ; Isaacson PG
Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
[TBL] [Abstract][Full Text] [Related]
24. HLA class II sublocus expression in benign and malignant breast epithelium.
Zuk JA; Walker RA
J Pathol; 1988 Aug; 155(4):301-9. PubMed ID: 2459333
[TBL] [Abstract][Full Text] [Related]
25. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
26. The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.
Möller P; Lämmler B; Herrmann B; Otto HF; Moldenhauer G; Momburg F
Immunology; 1986 Nov; 59(3):411-7. PubMed ID: 3491784
[TBL] [Abstract][Full Text] [Related]
27. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
28. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
[TBL] [Abstract][Full Text] [Related]
29. The DA6-147 monoclonal antibody raised against the HLA-DR alpha chain identifies a cryptic epitope on the BoLA-DR alpha chain.
Ababou A; Davis WC; Levy D
Vet Res; 1993; 24(5):402-7. PubMed ID: 7505154
[TBL] [Abstract][Full Text] [Related]
30. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression.
Al-Katib A; Koziner B
Br J Haematol; 1984 Jul; 57(3):373-82. PubMed ID: 6378248
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies for immunohistochemical labeling of immunocompetent cells in frozen sections of rhesus monkey tissues.
Stevens HP; van der Kwast TH; Timmermans A; Stouten N; Jonker M
J Med Primatol; 1991 Oct; 20(8):386-93. PubMed ID: 1803009
[TBL] [Abstract][Full Text] [Related]
32. Use of monoclonal antibodies for analyzing the distribution of the intermediate filament protein vimentin in human non-Hodgkin's lymphomas.
Giorno R; Sciotto CG
Am J Pathol; 1985 Sep; 120(3):351-5. PubMed ID: 2412444
[TBL] [Abstract][Full Text] [Related]
33. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
Guy K; Krajewski AS; Dewar AE
Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
[TBL] [Abstract][Full Text] [Related]
34. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
35. [Allogenic cartilage transplantation--immunohistochemical investigations on the antigenicity of the perichondrium].
Bujia J; Wilmer E; Hammer C; Kastenbauer E
Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):202-4. PubMed ID: 2095644
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma.
Smith ME; Holgate CS; Williamson JM; Grigor I; Quirke P; Bird CC
J Clin Pathol; 1987 Jan; 40(1):34-41. PubMed ID: 3546388
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant part of the HLA-DR antigens.
Sorg C; Bröcker EB; Zwadlo G; Redmann K; Feige U; Ax W; Feller AC
Transplantation; 1985 Jan; 39(1):90-3. PubMed ID: 2578237
[No Abstract] [Full Text] [Related]
38. In situ immunologic characterization of follicular lymphomas.
Ancelin E; Delsol G; Familiades J; Mason DY; Kuhlein E; Al Saati T; Laurent G; Huguet-Rigal F
Hematol Oncol; 1984; 2(3):221-37. PubMed ID: 6384007
[TBL] [Abstract][Full Text] [Related]
39. Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies.
Müller C; Ziegler A; Muller C; Hadam M; Waller HD; Wernet P; Müller G
Immunobiology; 1985 Apr; 169(3):228-49. PubMed ID: 3873401
[TBL] [Abstract][Full Text] [Related]
40. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
Borowitz MJ; Croker BP; Metzgar RS
Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
